CTRI/2023/11/059877尚未招募Unknown
Prevalence of Metabolic syndrome in mild Psoriasis: A Cross Sectional Study - NI
Dr Sathish Suriyaprakasam0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients must be diagnosed with mild psoriasis, defined as having a body surface area (BSA) of less than 10%.
- •Controls: Patients attending Dermatology OPD/STD OPD due to the disorders neither associated with nor prone to develop metabolic syndrome such as keloid, eczema, Sexually transmitted infections and normal patient attenders.
排除标准
- •Patients with psoriasis >10% BSA
- •Patients on phototherapy and systemic medications for psoriasis
- •Patients with Nail psoriasis, Psoriatic arthritis
- •Patients who are currently taking medications for any medical condition that may affect the prevalence of Metabolic syndrome.
- •Patients with pro-inflammatory skin conditions such as Acne, Atopic dermatitis, Alopecia, lichen planus, vitiligo, autoimmune disorders.
- •Patients who are not willing to consent for this study.
研究者
相似试验
尚未招募
不适用
Occurence of Metabolic Syndrome in patients with Heart failureCTRI/2022/10/046656KMC, Manipal
已完成
2 期
PREVALENCE OF METABOLIC SYNDROME IN PSORIASIS PATIENTS AND EVALUATION OF SAFETY AND EFFICACY OF INSULIN SENSITIZERS (METFORMIN AND PIOGLITAZONE) ON METABOLIC SYNDROME IN THESE PATIENTS IN RANDOMISED OPEN LABEL PLACEBO CONTROL TRIACTRI/2011/12/002252PGIMER98
招募中
不适用
Proportion of Metabolic Syndrome in Type II Diabetes patientsCTRI/2022/03/041435Dr Devashi Bharat Shukla
已完成
不适用
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin LevelsMetabolic SyndromePsoriatic ArthritisPsoriasis VulgarisNCT03932110Istanbul Medeniyet University180
已完成
不适用
Physical exercise and feeding influence over obesity, high pressure, diabetes and high cholesterol in adults and elderly from Santo Antônio de Goiás city.Adult and middle aged women, overweight or obese, sedentary lifestyle, abdominal obesity, any morbidity presence such hypertension, hyperglycemia or dyslipidemias.M01.975M01.060.116M01.060.116.630C23.888.144.699C18.654.726.500F01.829.458.705C18.654.726.500.697E05.318.308.985.525C14.907.489C18.452.394.952C18.452.584.500RBR-8rw7dzCoordenação de Aperfeiçoamento de Pessoal de Nível Superior